Is infectious disease diagnostics market a major segments in the global in-vitro diagnostics market?

Oct 16, 2020

The global infectious disease diagnostics market is one of the major segments in the global in-vitro diagnostics market.

According to the latest Arizton's market research report, the infectious disease diagnostics market size to cross $24 billion by 2025, growing at a CAGR of over 7% during the forecast period

Infectious Disease Diagnostics Market Growth

The global infectious disease diagnostics market is one of the major segments in the global in-vitro diagnostics market. The market is growing at a steady rate and is expected to grow at a similar pace during the forecast period. The surge in growth is attributed to the increasing prevalence/incidence of various infectious diseases. The increase in the usage of diagnostics tests for various purposes, such as routine health checkups, infectious diseases, seasonal flu, blood donation, blood preservations, and blood transfusion, fuels the market growth. Abbott, BD, F. Hoffmann-la Roche, Thermo Fisher Scientific, Quidel, and Luminex are the major global players in the infectious disease diagnosis market. The market is highly consolidated with key players accounting for major shares in the overall market.

Molecular Diagnostics Market

In the current market, molecular diagnostics for infectious disease testing is considered as one of the high potential technologies to witness increased growth and innovation. In 2019, the molecular diagnostics segment accounted for a share of around 34% in the global infectious disease diagnostics market. Molecular diagnostic assays are based on DNA amplification techniques. The advancements in molecular technologies and the shift in usage from traditional to molecular diagnosis is fueling the growth of the segment. Polymerase chain reaction (PCR) technology is one of the major revenue contributors in the molecular diagnostics market. Molecular diagnostics for infectious disease testing are mainly used by hospitals, academics institutions, and laboratories. Key players such as Roche Diagnostics and Danaher are entering the infectious disease molecular diagnostics market through several acquisitions and mergers. For instance, Roche Diagnostics entered the POC molecular diagnostics market after the acquisition of IQuum in April 2014. Several factors which are driving the demand for molecular diagnostics are as follows:

  • Fast Result
  • Antibiotic Resistance
  • Technological Advancements

Get your sample today!

Key Offerings:

  • Market Size & Forecast by Revenue | 2019−2025
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Segmentation – A detailed analysis by product, disease, end-user, tests, and geography
  • Competitive Landscape – 9 key vendors and 15 other vendors

Infectious Disease Diagnostics Market – Geographical Analysis

In 2019, APAC dominated the market, followed by Europe, North America, Latin America, and the Middle East & Africa. APAC is expected to be the fastest-growing region during the forecast period. This is attributed to the increasing target pool of people requiring various infectious disease diagnostics and improvement in healthcare infrastructure. China, Japan, India, South Korea, and Australia are the major revenue contributors to the APAC region. The European region is expected to witness growth owing to the increase in the prevalence of various infectious diseases, especially STDs, seasonal flu, along with a shift towards automated diagnostic analyzers and a rise in demand for POC diagnostics. In 2019, the US accounted for a share of around 87% in the North America infectious disease diagnostics market. The demand for infectious disease diagnostics tests in the US is increasing at a steady rate due to a rise in the prevalence of various infectious diseases and an increase in the volume of routine diagnostic tests as a broad majority of the general public prefers to take preventive measures.

Looking for more information? Click Here

About Arizton Advisory & Intelligence

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence

Chicago, Illinois, 60605

Mail: enquiry@arizton.com

Call: +1-312-235-2040/+1 302 469 0707

Oct 16, 2020

MI Procedures are Steering Atherectomy Devices Market Growth

The global atherectomy devices market is witnessing a new phase of technological advancements with t...

Oct 16, 2020

Is infectious disease diagnostics market a major segments in the global in-vitro diagnostics market?

The global infectious disease diagnostics market is one of the major segments in the global in-vitro...

Oct 15, 2020

Is the Outbreak of COVID-19 Increasing Traction for UV Germicidal Lamps?

The residential sector is witnessing increasing traction for UV germicidal lamps. ...

LATEST POSTS
VIEW RELATED REPORT

Infectious Disease Diagnostics Market - Global Outlook and Forecast 2020-2025

OTHER CATEGORIES